Zurich Cantonal Bank
AMRX icon

Zurich Cantonal Bank’s Amneal Pharmaceuticals AMRX Stock Holding History

Zurich Cantonal Bank’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Hold
100,944
– – ﹤0.01% 1215
2026
Q1 		$1.25M Buy
+100,944
New +$1.36M ﹤0.01% 1300
2025
Q4 		– Sell
-66,555
Closed -$762K – 2593
2025
Q3 		$666K Hold
66,555
– – ﹤0.01% 1557
2025
Q2 		$538K Buy
66,555
+9,279
+16% +$70K ﹤0.01% 1615
2025
Q1 		$480K Buy
57,276
+13,464
+31% +$112K ﹤0.01% 1623
2024
Q4 		$347K Buy
43,812
+8,860
+25% +$74.3K ﹤0.01% 1849
2024
Q3 		$291K Hold
34,952
– – ﹤0.01% 1896
2024
Q2 		$222K Buy
34,952
+4,115
+13% +$26.1K ﹤0.01% 1981
2024
Q1 		$187K Hold
30,837
– – ﹤0.01% 2082
2023
Q4 		$187K Buy
+30,837
New +$137K ﹤0.01% 2120
2023
Q2 		– Sell
-22,042
Closed -$30.6K – 2802
2023
Q1 		$30.6K Hold
22,042
– – ﹤0.01% 2698
2022
Q4 		$43.9K Buy
22,042
+15,454
+235% +$34.6K ﹤0.01% 2636
2022
Q3 		$13K Hold
6,588
– – ﹤0.01% 2845
2022
Q2 		$21K Hold
6,588
– – ﹤0.01% 2789
2022
Q1 		$27K Sell
6,588
-17
-0.3% -$75 ﹤0.01% 2628
2021
Q4 		$32K Buy
6,605
+17
+0.3% +$85 ﹤0.01% 2815
2021
Q3 		$35K Hold
6,588
– – ﹤0.01% 2712
2021
Q2 		$34K Hold
6,588
– – ﹤0.01% 2523
2021
Q1 		$44K Hold
6,588
– – ﹤0.01% 2421
2020
Q4 		$30K Hold
6,588
– – ﹤0.01% 2538
2020
Q3 		$26K Hold
6,588
– – ﹤0.01% 2434
2020
Q2 		$31K Hold
6,588
– – ﹤0.01% 2353
2020
Q1 		$23K Hold
6,588
– – ﹤0.01% 2298
2019
Q4 		$32K Hold
6,588
– – ﹤0.01% 2350
2019
Q3 		$19K Hold
6,588
– – ﹤0.01% 2464
2019
Q2 		$47K Buy
6,588
+1,125
+21% +$11.5K ﹤0.01% 2092
2019
Q1 		$77K Sell
5,463
-1,237
-18% -$16.3K ﹤0.01% 1735
2018
Q4 		$91K Buy
6,700
+1,477
+28% +$26.6K ﹤0.01% 1655
2018
Q3 		$116K Buy
+5,223
New +$110K ﹤0.01% 1628

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Zurich Cantonal Bank's AMRX Position: Q2 2026 in Review

Zurich Cantonal Bank held its Amneal Pharmaceuticals (AMRX) position steady in Q2 2026 at 100,944 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1215.

Zurich Cantonal Bank first reported a position in AMRX in Q3 2018 and has held it in 29 quarters since. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Zurich Cantonal Bank held 100,944 shares of Amneal Pharmaceuticals worth $1.75M as of Q2 2026.
  • Zurich Cantonal Bank left its Amneal Pharmaceuticals share count unchanged in Q2 2026.
  • Amneal Pharmaceuticals made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1215 holding.
  • Zurich Cantonal Bank first reported a position in Amneal Pharmaceuticals in Q3 2018 and has held it in 29 quarters since.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.